• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percentage of NDI notification reviews completed during the month within 75 days of filing

Dictionary: Timely review of notifications of new dietary ingredients impacts the public health by preventing substances that are not actually dietary ingredients from being used in dietary supplements, and assuring that new dietary ingredients have adequate evidence for presumption of safety. Since these statutory requirements are notifications rather than pre-market approvals, it is essential that ONLDS have completed review of the information before the submitter markets the product, to notify them of any safety or regulatory concerns before the product reaches consumers.

Information is current as of September 30, 2014.

Fiscal Year - 2010

Skip graphic and jump to text data

TimeAnnual TargetPercentage
Oct 200990100
Nov 20099075
Dec 200990100
Jan 201090100
Feb 201090100
Mar 201090100
Apr 201090100
May 20109086
Jun 20109080
Jul 20109080
Aug 201090100
Sep 201090N/A

FY 2010 Overall: 91%

Number of NDI notification reviews completed during the month within 75 days of filing

Fiscal Year - 2010
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2009N/A4
Nov 2009N/A3
Dec 2009N/A2
Jan 2010N/A2
Feb 2010N/A3
Mar 2010N/A6
Apr 2010N/A4
May 2010N/A6
Jun 2010N/A4
Jul 2010N/A4
Aug 2010N/A3
Sep 2010N/A0

FY 2010 Total: 41

Total number of NDI notification reviews completed during the month

Fiscal Year - 2010
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2009N/A4
Nov 2009N/A4
Dec 2009N/A2
Jan 2010N/A2
Feb 2010N/A3
Mar 2010N/A6
Apr 2010N/A4
May 2010N/A7
Jun 2010N/A5
Jul 2010N/A5
Aug 2010N/A3
Sep 2010N/A0

FY 2010 Total: 45

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.